Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2011 1
2012 1
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Reviewing the cost-effectiveness of endocrine early breast cancer therapies: influence of differences in modeling methods on outcomes.
Frederix GW, Severens JL, Hövels AM, Raaijmakers JA, Schellens JH. Frederix GW, et al. Value Health. 2012 Jan;15(1):94-105. doi: 10.1016/j.jval.2011.08.003. Epub 2011 Oct 1. Value Health. 2012. PMID: 22264977 Free article. Review.
The incremental cost-effectiveness ratios (ICERs) of the reported outcomes varied widely for identical therapies. For anastrazole compared to tamoxifen, incremental life-years gained even ranged from 0.16 to 0.550 with an ICER ranging from 3,958 to 75,331. ...To increase c …
The incremental cost-effectiveness ratios (ICERs) of the reported outcomes varied widely for identical therapies. For anastrazole compared t …
Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.
Wilcken N, Hornbuckle J, Ghersi D. Wilcken N, et al. Cochrane Database Syst Rev. 2003;2003(2):CD002747. doi: 10.1002/14651858.CD002747. Cochrane Database Syst Rev. 2003. PMID: 12804433 Free PMC article. Review.
SEARCH STRATEGY: The specialised register maintained by the Editorial Base of the Cochrane Breast Cancer Group was searched on 16th September 2002 using the codes for "advanced breast cancer", "chemotherapy" and "endocrine therapy". Details of the search strategy applied b …
SEARCH STRATEGY: The specialised register maintained by the Editorial Base of the Cochrane Breast Cancer Group was searched on 16th Septembe …
Tamoxifen-associated skin reactions in breast cancer patients: from case report to literature review.
Andrew P, Valiani S, MacIsaac J, Mithoowani H, Verma S. Andrew P, et al. Breast Cancer Res Treat. 2014 Nov;148(1):1-5. doi: 10.1007/s10549-014-3150-0. Epub 2014 Oct 8. Breast Cancer Res Treat. 2014. PMID: 25292419 Review.
Based on current medical literature, we present the first case of tamoxifen-induced ACLE. Our clinical experience of managing this case revealed that despite its broad use and the frequency of associated skin reactions, there is a lack of concise information deta …
Based on current medical literature, we present the first case of tamoxifen-induced ACLE. Our clinical experience of managing this ca …